If an executive’s employment is terminated by us without cause or
by the executive for good reason (as defined in the employment
agreement) and during a change of control period, the executive
will be entitled to (i) a lump sum cash payment equal to the
Accrued Amount, (ii) a lump sum cash payment equal to three
times the executive’s annual base salary, in the case of
Mr. DeBerry, and two times the annual base salary, in the case
of Messrs. Bird, Webster and Kumar, (iii) a lump sum cash
payment equal to a pro rata portion of the greater of the annual
cash incentive target for the year of termination or the average
annual cash incentive paid for the three most recent performance
periods (as defined in the employment agreement), (iv) a lump
sum cash payment in an amount equal to three times, in the case of
Mr. DeBerry, and two times, in the case of Messrs. Bird,
Webster and Kumar, the greater of the annual cash incentive target
for the year of termination or the average annual cash incentive
paid for the three most recent performance periods (as defined in
the employment agreement), (v) immediate vesting of any stock
options, restricted stock and performance units previously granted
to the executive and outstanding as of the time immediately prior
to the date of his termination, and (vi) continued medical,
dental and life insurance coverage until the earlier of the
executive’s receipt of equivalent coverage and benefits under other
plans of a subsequent employer or three years, in the case of
Messrs. DeBerry and Gariepy, or two years, in the case of Messrs.
Bird, Webster and Kumar.
If an executive’s termination is with cause at any time, other than
for good reason during a change of control period (as defined in
the employment agreement) or due to death or disability, the
executive will be entitled to (i) a lump sum cash payment
equal to the Accrued Amount and (ii) the provision of deferred
compensation and other employee benefits otherwise due.
Each executive is also subject to a perpetual covenant not to use
or disclose our trade secrets or confidential information and
non-competition and
non-solicitation covenants
during the term of his employment and for 12 months following his
termination.
In the event the change-of-control severance
benefits payable to the executive under the employment agreement
subject the executive to the “parachute payment” excise tax under
Section 4999 of the Code (“Excise Tax”) and the amount of the
parachute payment, reduced by all federal, state and local taxes
applicable thereto, including the Excise Tax, was less than the
amount the executive would receive if he were paid three times his
“base amount,” as defined in Section 280G(b)(3) of the Code,
less $1.00 (the “safe-harbor amount”), reduced by all federal,
state and local taxes applicable thereto, then the aggregate of the
amounts constituting the parachute payment would be reduced to the
safe-harbor amount. No Excise Tax “gross-up payment” will be made to or
on behalf of the executive by us.
Separation Agreement - Mr.
Gariepy
In connection with Mr. Gariepy’s retirement as our Senior Vice
President and Chief Operating Officer, we and Mr. Gariepy
agreed that Mr. Gariepy’s employment terminated effective
March 1, 2019 (the “Separation Date”) under circumstances
entitling him to severance under his employment agreement discussed
above under “— Employment Agreements with Executive Officers” and a
separation agreement and release we entered into with
Mr. Gariepy, effective as of the Separation Date (the
“Separation Agreement”). Pursuant to the terms of the Separation
Agreement, Mr. Gariepy received (i) a lump sum cash
payment equal to Mr. Gariepy’s base salary through the
Separation Date together with compensation for accrued vacation
time, (ii) a $1,125,000 lump sum cash payment equal to two
times Mr. Gariepy’s annual base salary, (iii) a lump sum
cash payment equal to $482,800, Mr. Gariepy’s annual cash
incentive for the fiscal year ended December 31, 2018, based
on actual performance results, (iv) immediate vesting of the
restricted stock previously granted to Mr. Gariepy and
outstanding as of the time immediately prior to the Separation
Date, valued at $1,732,213 based on the closing price of our common
stock on the vesting date, (v) continued vesting of
performance units outstanding as of the time immediately prior to
the Separation Date based on actual results at the end of the
relevant performance period and without any pro-rata adjustment for early
termination, and (vi) continued medical, vision, dental and
life insurance coverage until the earlier of Mr. Gariepy’s
receipt of equivalent coverage and benefits under other plans of a
subsequent employer or three years, valued at $57,767 based on the
annual cost of insurance to the Company net of premiums paid by
Mr. Gariepy with an assumed annual growth rate for such
insurance costs and discounted to a present value. These benefits
were in lieu of any of the benefits provided for under
Mr. Gariepy’s employment agreement.

38 2020 Proxy
Statement